MedTrace Logo

Hydroxyethyl Starch and Renal Function After Hip Replacement Surgery

NCT01486576 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2013-05-29

No results posted yet for this study

Summary

The purpose of this project is to investigate if hydroxyethyl starch (HES) is potential nephrotoxic and examine the effects on the circulation and kidneys during administration of HES during surgery.

Conditions

Interventions

DRUG

Voluven (Hydroxyethyl starch 130/0,4)

7,5 ml/kg in the first hour and then 5 ml/kg

DRUG

Sodium Chloride 9 mg/ml

7,5 ml/kg in the first hour and then 5 ml/kg

Sponsors & Collaborators

  • Regional Hospital Holstebro

    lead OTHER

Principal Investigators

  • Anne Sophie P. Kancir, MD PhD · Holstebo Regional Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01486576 on ClinicalTrials.gov